SLC2A3 and gastric cancer: In the TCGA dataset, survival analysis indicated that a high expression level of SLC2A3 was significantly associated with poor prognosis in patients with gastric cancer, both in overall survival (OS; p = 0.001; Figure 1C) and disease-specific survival (DSS; p = 0.008; Figure 1D).